» Articles » PMID: 8092825

Time-survival Studies for Quantifying Effects of Azlocillin and Tobramycin on Pseudomonas Aeruginosa

Overview
Specialty Pharmacology
Date 1994 Jun 1
PMID 8092825
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Time-survival studies were conducted to estimate the effects of azlocillin and tobramycin on Pseudomonas aeruginosa NCIMB 8295 (in the exponential phase of growth) at concentrations ranging from one-quarter to twice the MIC. The effects of the individual agents and their combinations were determined by measuring the viable counts (CFU per milliliter) over a 24-h period. The typical pattern observed from the plot of the logarithm of the CFU per milliliter against time was an initial rapid killing; this was followed by a period of stasis and regrowth. Initial rates of killing by tobramycin were concentration dependent, whereas this was not the case with azlocillin. From the time-survivor plots, the area under the curve for viable bacteria was also calculated. It offered a useful method of interpreting the results of time-kill studies, taking the overall pattern of killing and regrowth into consideration. The area under the curve for viable bacteria was concentration dependent for both antibiotics. A 2(2) factorial experimental design was used to analyze the joint effects of azlocillin and tobramycin. In such a factorial experiment, an interaction between two factors, in this case, azlocillin and tobramycin concentrations, is shown by a change in the slope of the plot when the concentration of the interactant is changed. Analysis of variance showed that the combination was synergistic at low concentrations, but this was not significant when the concentration of either interactant was increased.

Citing Articles

Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.

Yan Y, Yang G, Li Y, Mao J, Wang S, Zhang N Ann Transl Med. 2022; 10(3):148.

PMID: 35284561 PMC: 8904999. DOI: 10.21037/atm-21-4595.


Repurposing celecoxib as a topical antimicrobial agent.

Thangamani S, Younis W, Seleem M Front Microbiol. 2015; 6:750.

PMID: 26284040 PMC: 4517059. DOI: 10.3389/fmicb.2015.00750.


Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.

Pai M, Samples M, Mercier R, Spilde M Antimicrob Agents Chemother. 2008; 52(7):2367-76.

PMID: 18426896 PMC: 2443905. DOI: 10.1128/AAC.01557-07.


Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.

Ostergaard B, Hovde L, Rotschafer J Antimicrob Agents Chemother. 1996; 40(3):627-32.

PMID: 8851583 PMC: 163170. DOI: 10.1128/AAC.40.3.627.


Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

Tariq V, Scott E, McCain N Antimicrob Agents Chemother. 1995; 39(12):2615-9.

PMID: 8592989 PMC: 162999. DOI: 10.1128/AAC.39.12.2615.

References
1.
White A, Comber K, Sutherland R . Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1980; 18(1):182-9. PMC: 283961. DOI: 10.1128/AAC.18.1.182. View

2.
Bryan L, Kwan S . Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically. J Antimicrob Chemother. 1981; 8 Suppl D:1-8. DOI: 10.1093/jac/8.suppl_d.1. View

3.
NORDEN C, Shaffer M . Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982; 21(1):62-5. PMC: 181830. DOI: 10.1128/AAC.21.1.62. View

4.
Gerber A, Vastola A, Brandel J, Craig W . Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis. 1982; 146(5):691-7. DOI: 10.1093/infdis/146.5.691. View

5.
Gerber A, Craig W . Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice. J Lab Clin Med. 1982; 100(5):671-81. View